Taurine modulates catalytic activity of cytochrome P450 3A4

被引:0
|
作者
V. V. Shumyantseva
A. A. Makhova
T. V. Bulko
R. Bernhardt
A. V. Kuzikov
E. V. Shich
V. G. Kukes
A. I. Archakov
机构
[1] Orekhovich Institute of Biomedical Chemistry,Institute for Biochemistry
[2] Sechenov First Moscow State Medical University,undefined
[3] Saarland University,undefined
来源
Biochemistry (Moscow) | 2015年 / 80卷
关键词
cytochrome P450; antioxidants; drug metabolism; bioelectrochemistry; taurine;
D O I
暂无
中图分类号
学科分类号
摘要
The influence of the biologically active compound taurine on the stability and catalytic properties of the hemoprotein cytochrome P450 3A4 has been investigated. The catalytic properties were analyzed by electrochemical methods (cyclic and square-wave voltammetry) using cytochrome P450 3A4 immobilized on the electrode. Taurine at concentrations in the range 10–70 μM stimulated the electrochemical reduction of cytochrome P450 3A4, and the reduction was the highest (115 ± 3%) in the presence of 50 μM taurine. Taurine pronouncedly attenuated the itraconazol-caused inhibition of the P450 isoenzyme P450 3A4. Taurine protected cytochrome P450 3A4 due to stabilizing it during electrolysis at controlled voltage in the presence of erythromycin as a substrate. This protection was manifested by an increase in the amount of the “residual” reduced form of the hemoprotein (52 ± 5 and 71 ± 8%, respectively).
引用
收藏
页码:366 / 373
页数:7
相关论文
共 50 条
  • [41] Antiprogestin-mediated inactivation of cytochrome P450 3A4
    Jang, GR
    Benet, LZ
    PHARMACOLOGY, 1998, 56 (03) : 150 - 157
  • [42] Regioselectivity preference of testosterone hydroxylation by cytochrome P450 3A4
    Zhang, Yan
    Morisetti, Phani
    Kim, Jeffery
    Smith, Lynelle
    Lin, Hai
    THEORETICAL CHEMISTRY ACCOUNTS, 2008, 121 (5-6) : 313 - 319
  • [43] Involvement of human cytochrome P450 3A4 in the metabolism of vamidothion
    Mehmood, Z
    Kelly, DE
    Kelly, SL
    PESTICIDE SCIENCE, 1996, 46 (03): : 287 - 290
  • [44] Peripheral Ligand Binding and Allostery in Cytochrome P450 3A4
    Davydov, Dmitri R.
    Rumfeldt, Jessica A. O.
    Sineva, Elena V.
    Davydova, Nadezhda Y.
    Halpert, James R.
    FASEB JOURNAL, 2012, 26
  • [45] Approaches for increasing the electrocatalitic efficiency of cytochrome P450 3A4
    Shumyantseva, Victoria V.
    Koroleva, Polina I.
    Bulko, Tatiana, V
    Shkel, Tatyana, V
    Gilep, Andrei A.
    Veselovsky, Alexander V.
    BIOELECTROCHEMISTRY, 2023, 149
  • [46] Structural features of midazolam allostery by cytochrome P450 3A4
    Roberts, Arthur G.
    DRUG METABOLISM REVIEWS, 2011, 43 : 70 - 70
  • [47] Rate limiting steps in cytochrome P450 3A4 catalysis
    Krauser, JA
    Guengerich, FP
    FASEB JOURNAL, 2004, 18 (08): : C238 - C238
  • [48] Cytochrome P450 3A4 drug interaction profile of tofacitinib
    Krishnaswami, Sriram
    Lamba, Manisha
    Gupta, Pankaj
    Takiya, Liza
    Wang, Ronnie
    Kaplan, Irina
    Salageanu, Joanne
    Tarabar, Sanela
    Alvey, Christine
    Ndongo, Marie-Noella
    PHARMACOTHERAPY, 2012, 32 (10): : E240 - E240
  • [49] Fluorescent photoaffinity labeling of cytochrome P450 3A4 by lapachenole
    Wen, B
    Gartner, CA
    Cameron, MD
    Nelson, SD
    DRUG METABOLISM REVIEWS, 2003, 35 : 101 - 101
  • [50] Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
    Gruer, PJK
    Vega, JM
    Mercuri, MF
    Dobrinska, MR
    Tobert, JA
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (07): : 811 - 815